PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
111.14%
Revenue growth 1.25-1.5x CRON.TO's 100.00%. Bruce Berkowitz would examine if growth advantage is sustainable.
161.14%
Cost increase while CRON.TO reduces costs. John Neff would investigate competitive disadvantage.
91.08%
Gross profit growth exceeding 1.5x CRON.TO's 51.93%. David Dodd would verify competitive advantages.
-9.50%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-37.31%
R&D reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine competitive risk.
51.24%
G&A growth above 1.5x CRON.TO's 23.90%. Michael Burry would check for operational inefficiency.
55.33%
Marketing expense change of 55.33% while CRON.TO maintains spending. Bruce Berkowitz would investigate effectiveness.
47.21%
Other expenses growth above 1.5x CRON.TO's 1.28%. Michael Burry would check for concerning trends.
46.87%
Operating expenses growth above 1.5x CRON.TO's 20.61%. Michael Burry would check for inefficiency.
67.95%
Total costs growth above 1.5x CRON.TO's 16.82%. Michael Burry would check for inefficiency.
-22.41%
Both companies reducing interest expense. Martin Whitman would check industry trends.
11.97%
D&A growth above 1.5x CRON.TO's 1.28%. Michael Burry would check for excessive investment.
16.70%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
60.55%
EBITDA margin growth while CRON.TO declines. John Neff would investigate advantages.
10.33%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
57.53%
Operating margin growth while CRON.TO declines. John Neff would investigate advantages.
-9.02%
Other expenses reduction while CRON.TO shows 1182.73% growth. Joel Greenblatt would examine advantage.
10.46%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
57.59%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
-3279660318548.25%
Both companies reducing tax expense. Martin Whitman would check patterns.
10.46%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
57.59%
Net margin growth while CRON.TO declines. John Neff would investigate advantages.
10.98%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
10.98%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
-1.98%
Share count reduction while CRON.TO shows 1.29% change. Joel Greenblatt would examine strategy.
0.00%
Diluted share reduction exceeding 1.5x CRON.TO's 1.29%. David Dodd would verify capital allocation.